Viewing StudyNCT00310037



Ignite Creation Date: 2024-05-05 @ 4:48 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00310037
Status: UNKNOWN
Last Update Posted: 2021-08-18
First Post: 2006-03-29

Brief Title: Bortezomib After Combination Chemotherapy Rituximab and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
Sponsor:
Organization: Alliance for Clinical Trials in Oncology

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 151
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: